Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects (Q39743346)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects |
scientific article |
Statements
1 reference
Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects (English)
1 reference
Laurene H Wang
1 reference
Richard W Peck
1 reference
Yin Yin
1 reference
Jane Allanson
1 reference
Rebecca Wiggs
1 reference
Mary Beth Wire
1 reference
1 April 2003
1 reference
1 reference
47
1 reference
1334-1342
1 reference
Identifiers
1 reference
1 reference
1 reference